Research Article
Volume 10 Issue 3 - 2021
Ostojic Olivera1, Milosević Katarina2,3, Sagić Lidija4, Djuretic A5, Zivanovic Snezana6,7, Kostic Gordana8,9, Ivana Filipovic10, Vekovic Vesna1 and Zivkovic Zorica1,11*
Alexandru C Grigorescu*
1Children’s Hospital for Lung Diseases and Tuberculosis, Medical Center “Dr Dragisa Misovic”, Belgrade, Serbia
2University Children`s Hospital Belgrade, Serbia
3Faculty of Medicine, University of Belgrade, Serbia
4Municipal Institute for Lung Disease and Tuberculosis Belgrade, Serbia
5Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia
6Children Clinic, Clinical Center Niš, Niš, Serbia
7Faculty of Medicine, University of Niš, Niš, Serbia
8Children Clinic, Clinical Center Kragujevac, Kragujevac, Serbia
9Faculty of Medicine, University of Kragujevac, Kragujevac, Serbia
10Hospital for Gynecology and Obstetrics, Medical Center “Dr Dragisa Misovic”, Belgrade, Serbia
11Faculty of Pharmacy, University Business Academy in Novi Sad, Novi Sad, Serbia
*Corresponding Author: Zorica Zivkovic, Children’s Hospital for Lung Diseases and Tuberculosis, Medical Center “Dr Dragisa Misovic”, Belgrade, Serbia.
Received: January 27, 2021; Published: February 27, 2021




Abstract

Introduction and Objective: Allergic rhinitis (AR) is one of the common diseases among children. Through childhood, AR prevalence is between 30% to 40% in children and adolescents. It is usually underdiagnosed because the symptoms are nonspecific and accountable to recurrent colds. It has a negative impact on quality of life. The aim of this study is to evaluate the efficacy and safety of this natural nasal spray for symptoms relief in children with AR.

Patients and Methods: The study was conducted in the period from August 2017 to March 2018 as a multicentre, prospective study among 237 pediatric patients age 3 to 18 with allergic rhinitis. At the first visit, we took medical history data, demographic data, clinical symptoms (nasal congestion, itchy nose and eyes, sleepiness, duration of symptoms, time of occurrence), clinical examination was conducted and also allergy skin prick test and nasal swab. The children were given PropoMucil® allergy nasal spray (combination of standardized propolis with 12% of polyphenol and N-acetylcysteine, quercetin, thyme and eucalyptus essential oil and vitamin D3 and E; Abela Pharm, Belgrade, Serbia) to use it. Our patients used nasal spray, daily, for 30 days. At the second visit, patients fill out the questionnaire- about symptoms, therapy efficiency, favorability of spray taste, adverse effect.

Results: Out of the 237 patients, 60% were boys and 50% of children had up to 9 years. At the first visit, vast majority of the parents/caregivers - 90% of them, reported nasal obstruction in children, nasal itching in 69% and sneezing in 68%, fatigue and sleepiness in 22%. The allergy test was performed in 94% participants.

Persistent type of AR had 58% children. Moderate type of AR had 58% children, and 42% had mild form. Only 3% of children previously did not receive any treatment, while 97% were treated with antihistamines and/or nasal corticosteroid therapy. After 30 days therapy with PropoMucil® allergy nasal spray, number of subjects with no nasal itching was 55% and no nasal congestion, 60%. 7% of children reported adverse effects: tingling nose, nasal bleeding, watery eyes, itchy nose, sneezing.

Conclusion: The combination propolis, N-acetylcysteine, quercetin, thyme and eucalyptus essential oil and vitamin D3 and E in nasal spray is a good choice for the treatment of allergic rhinitis in children. About 80% of parents said that this nasal spray improved overall health in their children.

 

Keywords: Allergic Rhinitis; Nasal Congestion; Children; Propolis; N-Acetylcysteine

References

    1. Brożek JL., et al. “Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision”. The Journal of Allergy and Clinical Immunology 03 (2010): 466-476.
    2. , et al. “The future outlook on allergen immunotherapy in children: 2018 and beyond”. Italian Journal of Pediatrics 44 (2018): 80.
    3. Pawankar R., et al. “Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008”. World Allergy Organization Journal 3 (2012): S212-S217.
    4. MS Blaiss., et al. “The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents A literature review”. Annals of Allergy, Asthma and Immunology 121 (2018): 43-52.
    5. Luna Mde F., et al. “Prevalence of rhinitis among 6 and 7-year old students in Fortaleza”. Revista da Associação Médica Brasileira 04 (1992): 357-364.
    6. Turner PJ and Kemp AS. “Allergic rhinitis in children”. Journal of Paediatrics and Child Health 4 (2010): 302-310.
    7. Westman M., et al. “Natural course and comorbidities of allergic and nonallergic rhinitis in children”. The Journal of Allergy and Clinical Immunology 2 (2012): 403-408.
    8. Dykewicz MS and Hamilos DL. “Rhinitis and sinusitis”. The Journal of Allergy and Clinical Immunology 2-2 (2010): S103-S115.
    9. Kemp AS. “Allergic rhinitis”. Paediatric Respiratory Reviews 2 (2009): 63-68.
    10. Linneberg A., et al. “Burden of allergic respiratory disease: a systematic review”. Clinical and Molecular Allergy 14 (2016): 12.
    11. Meltzer EO., et al. “Burden of allergic rhinitis: results from the Pediatric Allergies in America survey”. The Journal of Allergy and Clinical Immunology 124 (2009): S43-S70.
    12. Martins Da Silva C., et al. “Quality of life in children and adolescents with allergic rhinitis”. Revista Brasileira de Otorrinolaringologia 05 (2009): 642-649.
    13. Lunn M and Craig T. “Rhinitis and sleep”. Sleep Medicine Reviews 5 (2011): 293-299.
    14. Everhart RS., et al. “Allergic rhinitis quality of life in urban children with asthma”. Annals of Allergy, Asthma and Immunology 04 (2014): 365-370.
    15. , et al. “Health-related quality of life by allergy symptoms in elementary school students”. Health and Quality of Life Outcomes 16 (2018): 93.
    16. Meltzer EO., et al. “Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations”. The Journal of Family Practice 2 (2012): S5-S10.
    17. Cardell L-O., et al. “TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study”. NPJ Primary Care Respiratory Medicine 26 (2016): 15082.
    18. Castro PG., et al. “The impact of environmental factors on quality of life and symptoms of children with allergic rhinitis”. Brazilian Journal of Otorhinolaryngology 5 (2013): 569-574.
    19. , et al. “Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: Studies of nasal scrapings and their dispersed cells”. The Journal of Allergy and Clinical Immunology (1995): s528-536.
    20. Dales RE., et al. “Respiratory illness in children attending daycare”. Pediatric Pulmonology 1 (2004): 64-69.
    21. Zivković Z., et al. “Prevalence of childhood asthma and allergies in Serbia and Montenegro”. World Journal of Pediatrics 4 (2010): 331-336.
    22. Dziekanski M and Marcelino TF. “Qualiti of Life in Pediatric Patients with Allergic Rhinitis treated at the Medical Clinic of Integrated Education – Unisul”. International Archives of Otorhinolaryngology 21 (2017): 371-376.
    23. Juniper E., et al. “Measuring quality of life in children with rhinoconjuctivitis”. The Journal of Allergy and Clinical Immunology 101 (1998): 163-170.
    24. Meltzer EO., et al. “Treatment of congestion in upper respiratory diseases”. International Journal of General Medicine 3 (2010): 69-91.
    25. Craig TJ., et al. “Congestion and sleep impairment in allergic rhinitis”. Current Allergy and Asthma Reports 2 (2010): 113-121.
    26. Sardana N and Craig TJ. “Congestion and sleep impairment in allergic rhinitis”. Asian Pacific Journal of Allergy and Immunology 4 (2011): 297-306.
    27. Al Sayyad JJ., et al. “Topical nasal steroids for intermittent and persistent allergic rhinitis in children”. The Cochrane Database of Systematic Reviews 1 (2007): CD003163.
    28. Baena-Cagnani CE. “Safety and tolerability of treatments for allergic rhinitis in children”. Drug Safety 27 (2004): 883-898.
    29. Filipović I and Filipović Đ. “Atopijski mars”-od atopijskog dermatitisa do alergijskog rinitisa i astme”. Naučni Časopis Urgentne Medicine - Halo3 (2011): 102-112.
    30. Filipović I., et al. “Asthma in Adolescent’s Ages”. Prev Ped1-2 (2020): 61-64.
    31. Caminati M., et al. “Respiratory allergies in childhood: Recent advances and future challenges”. Pediatric Allergy and Immunology 8 (2015): 702-710.
    32. Scadding G. “Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments”. Paediatric Drugs3 (2008): 151-162.
    33. Fernandes A Jr., et al. “Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs”. Memórias do Instituto Oswaldo Cruz 5 (2005): 563-566.
    34. Sagić L., et al. “Efficiency of a Dietary Supplement in Children”. Medicinski Pregled6 (2018): 180-185.
Citation: Zivkovic Zorica., et al. “Efficacy and Safety of Unique Natural Combination Spray for Symptoms Relief in Children with Allergic Rhinitis”. EC Pulmonology and Respiratory Medicine 10.3 (2021): 76-86.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 21, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk